Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)
China · Delayed Price · Currency is CNY 16.93
-0.01 (-0.06%)
Sep 4, 2026, 3:00 PM CST
Shanghai ZJ Bio-Tech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,451 | 2,553 | 2,783 | 2,769 | 3,148 | 2,936 |
Trading Asset Securities | 342.94 | 347.89 | - | - | - | - |
Cash & Short-Term Investments | 2,794 | 2,901 | 2,783 | 2,769 | 3,148 | 2,936 |
Cash Growth | -0.84% | 4.21% | 0.50% | -12.02% | 7.21% | 143.70% |
Accounts Receivable | 32.58 | 31.79 | 55.27 | 102.1 | 227.63 | 218.39 |
Other Receivables | 0.48 | 0.59 | 22.78 | 25.05 | 9.45 | 75.76 |
Receivables | 33.05 | 32.38 | 78.05 | 127.15 | 237.08 | 294.15 |
Inventory | 38.39 | 45.57 | 57.37 | 253.6 | 504.03 | 299.47 |
Other Current Assets | 11.78 | 7.62 | 16.8 | 15.79 | 21.01 | 23.3 |
Total Current Assets | 2,878 | 2,986 | 2,936 | 3,166 | 3,910 | 3,553 |
Property, Plant & Equipment | 602.41 | 628.22 | 680.95 | 743.91 | 661.63 | 562.36 |
Long-Term Investments | 73.2 | 64.93 | 95.46 | 101.05 | 113.46 | 74.97 |
Goodwill | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 |
Other Intangible Assets | 26.7 | 7.04 | 7.8 | 6.06 | 6.84 | 6.57 |
Long-Term Deferred Tax Assets | 68.18 | 68.81 | 60.8 | 37.16 | 9.46 | 7.44 |
Long-Term Deferred Charges | 2.86 | 3.2 | 3.82 | 2.86 | 3.66 | - |
Other Long-Term Assets | - | - | 0.11 | 11.71 | 33.55 | 45.1 |
Total Assets | 3,656 | 3,764 | 3,790 | 4,074 | 4,744 | 4,255 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 50.73 | 38.16 | 78.75 | 120.58 | 317.67 | 236.95 |
Accrued Expenses | 34.75 | 60.47 | 43.67 | 74.03 | 99.78 | 75.92 |
Current Portion of Long-Term Debt | 11.5 | 9.93 | - | - | - | - |
Current Portion of Leases | - | 1.82 | 1.73 | 2.81 | 2.94 | - |
Current Income Taxes Payable | 2.91 | 0.06 | 0.09 | 0.01 | 26.82 | 32.28 |
Current Unearned Revenue | 7.56 | 9 | 15.28 | 24.02 | 59.32 | 55.29 |
Other Current Liabilities | 5.92 | 7.15 | 6.46 | 15.12 | 17.33 | 8.56 |
Total Current Liabilities | 113.37 | 126.58 | 145.99 | 236.56 | 523.86 | 409 |
Long-Term Debt | 279.14 | 284.26 | - | - | - | - |
Long-Term Leases | 2.16 | 2.96 | 3.19 | 4.64 | 5.69 | - |
Long-Term Unearned Revenue | 0.99 | 1.14 | 3.88 | 7.59 | 11.71 | 13.74 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.45 | 2.17 | 4.54 |
Total Liabilities | 395.66 | 414.95 | 153.06 | 249.25 | 543.44 | 427.27 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 192.16 | 192.16 | 192.16 | 194.7 | 194.7 | 194.7 |
Additional Paid-In Capital | 2,051 | 2,051 | 2,051 | 2,150 | 2,150 | 2,150 |
Retained Earnings | 1,370 | 1,410 | 1,438 | 1,587 | 1,953 | 1,458 |
Treasury Stock | -339.01 | -294.44 | -35.33 | -102.03 | -102.03 | - |
Comprehensive Income & Other | -12.94 | -9.87 | -8.88 | -4.51 | 4.73 | 24.35 |
Total Common Equity | 3,261 | 3,349 | 3,637 | 3,825 | 4,200 | 3,827 |
Shareholders' Equity | 3,261 | 3,349 | 3,637 | 3,825 | 4,200 | 3,827 |
Total Liabilities & Equity | 3,656 | 3,764 | 3,790 | 4,074 | 4,744 | 4,255 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 292.81 | 298.97 | 4.93 | 7.45 | 8.63 | - |
Net Cash (Debt) | 2,502 | 2,602 | 2,778 | 2,762 | 3,139 | 2,936 |
Net Cash Growth | -4.37% | -6.36% | 0.60% | -12.01% | 6.92% | 143.70% |
Net Cash Per Share | 14.69 | 14.41 | 14.60 | 14.33 | 16.23 | 15.40 |
Filing Date Shares Outstanding | 182.88 | 175.71 | 189.84 | 192.16 | 192.16 | 194.7 |
Total Common Shares Outstanding | 182.88 | 175.71 | 189.84 | 192.16 | 192.16 | 194.7 |
Working Capital | 2,764 | 2,860 | 2,790 | 2,929 | 3,386 | 3,144 |
Book Value Per Share | 17.83 | 19.06 | 19.16 | 19.91 | 21.86 | 19.66 |
Tangible Book Value | 3,229 | 3,336 | 3,624 | 3,813 | 4,188 | 3,815 |
Tangible Book Value Per Share | 17.65 | 18.99 | 19.09 | 19.85 | 21.80 | 19.60 |
Buildings | - | 772.93 | 770.99 | 757.66 | 639.77 | 547.36 |
Machinery | - | 160.52 | 156.51 | 208.32 | 194.57 | 145.72 |
Construction In Progress | - | 0.03 | 0.34 | 2.12 | 1.18 | 0.98 |